Cargando…

Exacerbation of livedoid vasculopathy after Coronavirus disease 2019

Detalles Bibliográficos
Autores principales:	Kawabe, Ryoko, Tonomura, Kyoko, Kotobuki, Yorihisa, Ueda-Hayakawa, Ikuko, Murota, Hiroyuki, Fujimoto, Manabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Libbey Eurotext 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170554/ https://www.ncbi.nlm.nih.gov/pubmed/35653093 http://dx.doi.org/10.1684/ejd.2022.4200

Ejemplares similares

Clinical and dermoscopic features of livedoid vasculopathy
por: Wen, Juan, et al.
Publicado: (2020)

Dermoscopic features of livedoid vasculopathy
por: Hu, Stephen Chu-Sung, et al.
Publicado: (2017)

Successful treatment of livedoid vasculopathy with rivaroxaban
por: Evans, John M., et al.
Publicado: (2015)

Livedoid vasculopathy: a compelling diagnosis
por: Freitas, Thiago Quadrante, et al.
Publicado: (2018)

Ulcerative livedoid vasculopathy responding to clopidogrel
por: Kunzler, Elaine, et al.
Publicado: (2018)

Adalimumab in Treating Refractory Livedoid Vasculopathy
por: Huang, Xiao-Wen, et al.
Publicado: (2022)

Livedoid Vasculopathy: diagnosis and treatment in pregnant women
por: Bezerra, Alexandre Sacchetti, et al.
Publicado: (2020)

Livedoid vasculopathy – A diagnostic and therapeutic challenge
por: Burg, Maria Rosa, et al.
Publicado: (2022)

Penile Livedoid Vasculopathy: First Reported Case
por: Hallak, Ahmad, et al.
Publicado: (2023)

Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy
por: Ray, Rahul, et al.
Publicado: (2015)

Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy
por: Chen, Wenji, et al.
Publicado: (2017)

A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide
por: Song, Chang Hwa, et al.
Publicado: (2020)

Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy
por: Han, Yuyang, et al.
Publicado: (2022)

Vascular Disease Patient Information Page: Livedoid vasculopathy
por: Eswaran, Harish, et al.
Publicado: (2022)

Livedoid vasculopathy: A review with focus on terminology and pathogenesis
por: Eswaran, Harish, et al.
Publicado: (2022)

Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib
por: Jia, Ertao, et al.
Publicado: (2020)

Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management
por: Bilgic, Asli, et al.
Publicado: (2021)

Botulinum toxin-A: A novel treatment for livedoid vasculopathy
por: Crotty, Angela M., et al.
Publicado: (2022)

Detection of Bartonella henselae DNA in the blood of patients with livedoid vasculopathy()
por: Drummond, Marina Rovani, et al.
Publicado: (2023)

Livedoid vasculopathy as a marker of systemic disease: report of two cases
por: Lima, Raquel Sucupira Andrade, et al.
Publicado: (2014)

Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases
por: Tubone, Mariana Quirino, et al.
Publicado: (2013)

Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy
por: Saoji, Vikrant, et al.
Publicado: (2017)

Fast Cicatrization of Extensive Livedoid Vasculopathy Ulcers under Treatment with Sildenafil
por: Lopes, Lediane Moreira, et al.
Publicado: (2017)

Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy
por: Edminister, John R., et al.
Publicado: (2019)

Livedoid vasculopathy and its association with genetic variants: A systematic review
por: Gao, Yimeng, et al.
Publicado: (2021)

Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy
por: Palanisamy, Nageshwari, et al.
Publicado: (2023)

Evaluating complement dysregulation in livedoid vasculopathy using a functional assay
por: Eswaran, Harish, et al.
Publicado: (2023)

A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy
por: Seguí, Mireia, et al.
Publicado: (2022)

Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation
por: Mirrakhimov, Aibek E., et al.
Publicado: (2012)

SAT-232 Pheochromocytoma Presenting Rare Skin Findings: Livedoid Vasculopathy and Raynaud’s Phenomenon
por: Kyo, Chika, et al.
Publicado: (2020)

Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
por: Gao, Yimeng, et al.
Publicado: (2022)

Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review
por: Ramphall, Shivana, et al.
Publicado: (2022)

A case of concomitant clinical and histopathologic features of lymphocytic thrombophilic arteritis and livedoid vasculopathy
por: Gan, Christian, et al.
Publicado: (2023)

Acute Central Retinal Artery Occlusion Associated with Livedoid Vasculopathy: A Variant of Sneddon's Syndrome
por: Song, Hyun Beom, et al.
Publicado: (2013)

Therapeutic effect of autologous platelet-rich plasma (PRP) on recalcitrant cutaneous ulcers in livedoid vasculopathy
por: Kawakami, Tamihiro, et al.
Publicado: (2015)

Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
por: Yoshioka, Katsunobu, et al.
Publicado: (2018)

Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level
por: Kofler, Katrin, et al.
Publicado: (2021)

Clinical, Laboratory, Histopathological and Therapeutic Profile of Livedoid Vasculopathy: A Case Series of 17 Patients
por: Shah, Shikha R., et al.
Publicado: (2022)

Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review
por: Gao, Yimeng, et al.
Publicado: (2022)

A Case of Pretibial Epidermolysis Bullosa with Novel Mutations of the COL7A1 Gene
por: Shimizu, Yuri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vld8n2lonbcfenacdsdfn054ib